POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONS

Within recent years, a special attention has been paid to the nonspecific prevention of the acute respiratory disease related to the increase of the activity of the natural mechanisms for antiviral protection. The application of the liposomal forms of the different medications contributes to the dir...

Full description

Saved in:
Bibliographic Details
Main Authors: M.K. Erofeeva, V.L. Maksakova, M.G. Pozdnyakova, I.L. Kolyvanova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2007-01-01
Series:Вопросы современной педиатрии
Online Access:https://vsp.spr-journal.ru/jour/article/view/1001
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839575551385272320
author M.K. Erofeeva
V.L. Maksakova
M.G. Pozdnyakova
I.L. Kolyvanova
author_facet M.K. Erofeeva
V.L. Maksakova
M.G. Pozdnyakova
I.L. Kolyvanova
author_sort M.K. Erofeeva
collection DOAJ
description Within recent years, a special attention has been paid to the nonspecific prevention of the acute respiratory disease related to the increase of the activity of the natural mechanisms for antiviral protection. The application of the liposomal forms of the different medications contributes to the directed transportation of the biodegraded protein substances. A special interest is aroused by the opportunity to orally apply protein medications, as their injection forms quickly degrade in the stomach. New Russian liposomal recombinant alphac2b interferon has antiviral, immuno-modulating and interferonogenic activity. The work demonstrates experience of the oral application form of the liposomal medication of recombinant alphac2b interferon — reaferoncesclipint for the extra prevention of flu and other acute respiratory infections among children. The application of this medication to prevent flu and acute respiratory infections in the dose of 250,000 Ме twice a week for the 4 weeks' period proved to be efficient within the group of the preschool children (aged between 7–10 years old) and manifested itself in the reduction of the flu and acute respiratory infections recurrence.Key words: flu, prevention, efficiency index, interferon.
format Article
id doaj-art-acf2922f1d764f97ad57a0a06c53d0f9
institution Matheson Library
issn 1682-5527
1682-5535
language English
publishDate 2007-01-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj-art-acf2922f1d764f97ad57a0a06c53d0f92025-08-04T13:09:33Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352007-01-016180841002POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONSM.K. Erofeeva0V.L. Maksakova1M.G. Pozdnyakova2I.L. Kolyvanova3Research Institute of Flu, Russian Academy of Medical Sciences, Saint PetersburgResearch Institute of Flu, Russian Academy of Medical Sciences, Saint PetersburgResearch Institute of Flu, Russian Academy of Medical Sciences, Saint PetersburgResearch Institute of Flu, Russian Academy of Medical Sciences, Saint PetersburgWithin recent years, a special attention has been paid to the nonspecific prevention of the acute respiratory disease related to the increase of the activity of the natural mechanisms for antiviral protection. The application of the liposomal forms of the different medications contributes to the directed transportation of the biodegraded protein substances. A special interest is aroused by the opportunity to orally apply protein medications, as their injection forms quickly degrade in the stomach. New Russian liposomal recombinant alphac2b interferon has antiviral, immuno-modulating and interferonogenic activity. The work demonstrates experience of the oral application form of the liposomal medication of recombinant alphac2b interferon — reaferoncesclipint for the extra prevention of flu and other acute respiratory infections among children. The application of this medication to prevent flu and acute respiratory infections in the dose of 250,000 Ме twice a week for the 4 weeks' period proved to be efficient within the group of the preschool children (aged between 7–10 years old) and manifested itself in the reduction of the flu and acute respiratory infections recurrence.Key words: flu, prevention, efficiency index, interferon.https://vsp.spr-journal.ru/jour/article/view/1001
spellingShingle M.K. Erofeeva
V.L. Maksakova
M.G. Pozdnyakova
I.L. Kolyvanova
POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONS
Вопросы современной педиатрии
title POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONS
title_full POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONS
title_fullStr POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONS
title_full_unstemmed POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONS
title_short POSSIBILITY TO APPLY LIPOSOMAL ALPHA-2B INTERFERON FOR THE PREVENTION OF FLU AND OTHER ACUTE RESPIRATORY INFECTIONS
title_sort possibility to apply liposomal alpha 2b interferon for the prevention of flu and other acute respiratory infections
url https://vsp.spr-journal.ru/jour/article/view/1001
work_keys_str_mv AT mkerofeeva possibilitytoapplyliposomalalpha2binterferonforthepreventionoffluandotheracuterespiratoryinfections
AT vlmaksakova possibilitytoapplyliposomalalpha2binterferonforthepreventionoffluandotheracuterespiratoryinfections
AT mgpozdnyakova possibilitytoapplyliposomalalpha2binterferonforthepreventionoffluandotheracuterespiratoryinfections
AT ilkolyvanova possibilitytoapplyliposomalalpha2binterferonforthepreventionoffluandotheracuterespiratoryinfections